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Definition of the Blue Bioeconomy
Further information on the Blue Bioeconomy Forum can be found at the website of DG MARE https://ec.europa.
eu/maritimeaffairs/index_en as well as on http://bluebioeconomyforum.eu. Here, pdf-versions of this brochure 
as well as the roadmap may be downloaded. 
The European Commission defines Bioeconomy as:
“the production of renewable biological resources and the conversion of these resources and waste 
streams into value added products, such as food, feed, bio-based products and bioenergy.” (European 
Commission, 2012). 
The addition of “blue” entails a focus on aquatic or marine environments, especially, on novel aquacul-
ture applications, including non-food, food and feed. Within the scope of the Blue Bioeconomy Forum, 
the study does not cover “traditional” uses of biomass, such as fisheries and traditional aquaculture 
that are mainly aimed at food. Marine organisms that are covered include amongst others: microbes 
(e.g. bacteria, fungi), microalgae, macroalgae (seaweed), invertebrates (e.g. crustaceans, annelids, mol-
luscs, porifera) and discards of fish and other marine organisms that show potential for the develop-
ment of innovative and high value products as well as valorisation of co-products.
INTRODUCTION
The Directorate General for Maritime Affairs and Fisheries (DG MARE) of the European Commission 
and the Executive Agency for Small and Medium Sized Enterprises (EASME) have initiated the Blue 
Bioeconomy Forum (BBF) in 2018 to bring together industry, public authorities, academia, finance 
and civil society in order to strengthen Europe’s competitive position, exploit the potential and en-
sure the sustainable use of the resources of the emerging blue bioeconomy. 
The aim of the BBF is to develop a common understanding of the current status of blue bioecono-
my in Europe and to collectively identify strategic developments, market opportunities, appropriate 
financial assistance, regulatory actions and research priorities. The BFF seeks to exploit synergies 
between blue bioeconomy sectors which can benefit from the innovative and optimal uses of 
aquatic biomass, by sourcing biomass for a particular purpose (e.g. for high-value applications such 
as pharmaceuticals), but also by valorising by-products and ecosystem services.
For that purpose, the BBF project team, in a joint effort with its Steering Group members, thematic 
Working Groups and the active involvement of the wider blue bioeconomy community (the Forum) 
has designed and developed a Roadmap. In that roadmap, the BBF identified 14 challenges that fall 
within four main themes: Policy, environment and regulation; Finance and business development; 
Consumers and supply chains; Science, technology and innovation. With the support of the BBF 
community, solutions were identified to tackle the challenges. A summary of the challenges and 
solutions per theme can be found on the next pages.
Furthermore, the BBF identified and collected examples of projects and/or start-up companies 
that not only highlight Europe’s potential in the blue bioeconomy, but are also sufficiently close to 
commercialisation that they would deserve attention from a wide range of stakeholders, ranging 
from policy-makers to investors. A selection of these examples are shown in the second part of this 
brochure.
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POLICY, ENVIRONMENT   
AND REGULATION
A range of challenges in the blue bioec-
onomy lie in the legal realm: not only are 
definitions, rules, governance and activities 
currently unclear but potential activities 
and businesses may fall in different policy 
fields: fishery, aquaculture, marine agron-
omy, agriculture, bioindustries - are all 
logical candidates but separately, none of 
them sufficiently cover the width of the blue 
bioeconomy.
Clarification can be achieved mostly through 
formal standards as developed and promot-
ed by standardisation bodies, while some 
issues will remain of a more political nature.
One-stop-shops, set up by local, regional 
and European governments, for businesses 
operating in the blue bioeconomy can be 
one way of reducing the burden of op-
erating in this new and upcoming sector: 
it would mean that regional or national 
governments would have to provide support 
to businesses.
Novel foods offer opportunities to commer-
cialise high-value products. Effective im-
plementation of the Novel Food Regulation 
(NFR)  is important to protect EU citizen’s 
health, but also to protect the sector from 
unfair competition .
A number of blue bioeconomy activi-
ties can also provide ecosystem services, 
that could be valorised as instruments to 
achieve EU environmental targets.
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Policy, Environment and Regulation
Challenges Solutions
Licences 
/ Permits
Simplify licence and permit applications
- Harmonise regulatory and legislative requirements
- Improve clarity about activities through the establishment and adoption of standards
- Provide clarity on the status of underutilised marine biomass
-  Create one-stop-shops where businesses can obtain (free) advice on regulations in blue bioeconomy sector  
and product requirements
- Work towards the harmonisation of marine spatial planning and multi-use
Novel food  
and feed
Offer support for applications under the Novel Food Regulation
- Conduct the necessary studies for the authorisation of more types of biomass
- Ensure the accuracy and consistency of the EU novel food list
- Provide necessary support to novel food applicants
Ecosystem  
services
Valorise ecosystem services
- Take stock of ecosystem services pilots and support their deployment
-  Secure high-level support for payments for ecosystem services and create cohesion between Common Agricul-
ture and Common Fishery Policies
- EU strategy for an institutional framework for ecosystem services across European sea basins
- Incorporate marine ecosystem services into macro-regional strategies, projects and initiatives 
-  Ensure that ecosystem valuation studies become an integral part in decision models for specific marine  
management decisions
Table 1: Challenges and solutions in Policy, Environment and Regulation
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FINANCE AND BUSINESS   
DEVELOPMENT
Financing is required for start-ups and small 
businesses in the blue bioeconomy when 
moving through the different phases of 
technology development and commercialisa-
tion of the business. Many businesses do not 
have this expertise in-house, and it is recom-
mended that financial planning & resources 
are brought in at the appropriate time. 
Investments in the blue bioeconomy 
will require significant amounts of capital 
and a strong involvement of both private 
and public stakeholders. To address the 
lack of financing for blue bioeconomy 
start-ups and SMEs, dedicated investment 
funds should be established. This has been 
proposed within the framework of the new 
BlueInvest platform. National, regional and 
local authorities should consider contributing 
to such a platform and establish a matching 
fund mechanism.
New national and regional funds dedicated 
to the blue bioeconomy could be envisaged, 
although earmarking EU structural and 
investment funds is also an option. Blended 
finance models will continue to develop in 
this sector and any of these initiatives or 
mechanisms should provide the opportunity 
for investment management companies to 
participate as investing partners .
Over the longer term, the blue bioeconomy 
sector could benefit from policy instruments, 
such as technology subsidies or partnership 
initiatives, to partially offset high produc-
tion costs. This is particularly important for 
sub-sectors offering social and environmen-
tal benefits, including ecosystem services.
The skills required for blue bioeconomy 
business success become more complex 
with each phase of product development. 
Whereas in initial phases the needs are for 
specialised technical skills, in latter phases, 
these are expanded to include business skills. 
Members of the investment community ac-
tive in the blue bioeconomy have remarked 
that entrepreneurs and project leaders often 
lack necessary business skills for growing a 
small startup or business. The lack of multi-
disciplinary skills can constitute a bottleneck 
to innovation .
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Finance and Business Development
Challenges Solutions
Understanding 
finance
Increase understanding of investment landscape for projects and businesses
- Provide blue bioeconomy start-ups with advice on business and financing
Funding  
mechanisms
Promote uptake of existing funding mechanisms and set up new ones to support projects  
and start-ups
- Establish investment funds for blue bioeconomy
- Provide additional support to SMEs in the blue bioeconomy sector
Skills and  
qualifications
Ensure availability of skilled and qualified human resources
- Upcoming sectors and start-ups require more flexible skilled people (including basic business skills)
Table 2: Challenges and solutions in Finance and Business Development
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CONSUMERS   
AND VALUE CHAINS
The qualities, health benefits, functionali-
ties and utilities of blue biomass/products 
are still hotly debated. As a result, the type 
and amount of public support, as well as 
consumer awareness and acceptance of 
novel products is limited. To raise consumer 
acceptance of blue products, the value of 
these products needs to be more widely 
understood, and reciprocally, producers 
should recognise concerns among potential 
consumers (such as price, sustainability, and 
health benefits).
Reinforcing the need to find solutions to rest 
raw material valorisation is important, as 
currently the discards in the fish process-
ing industry reach up to 75 % of the total 
volume of processed products.
Entrepreneurs in the blue bioeconomy 
sector face relatively high production costs, 
due to a lack of available and accessible 
production/processing facilities, as well as 
risks and expenses during the R&D phase.
35% of consulted Blue Bioeconomy Forum 
stakeholders face logistical challenges, of 
which 80% are technical in nature (and not 
legal or policy issues). Technical challenges 
include complex and expensive operations 
throughout the entire supply chain, includ-
ing harvesting, storing, processing, transport 
and delivery.
Lack of access to data on pollution, quality 
and temperature of water prevents entre-
preneurs from optimising their production 
process. Ensuring open access to such data, 
as well as integrating various monitoring 
data sources in one platform, requires joint 
action by public, research and industry 
actors .
Dissemination and exchange of existing 
good practices on distributed harvesting, 
processing of biomass, optimisation of the 
logistics of by-catch fishing resources would 
be helpful.
Blue Bioeconomy Forum ~ Roadmap for the blue bioeconomy12
Consumers and Value Chains
Challenges Solutions
Consumer 
acceptance
Increase consumer awareness and acceptance 
- Improve understanding on the value of blue products
- Define a communication strategy to raise consumer awareness of blue products
- Design more supportive regional policies on blue sector 
- Support the blue sector advocacy groups in the EU 
Side 
products
Increase the valorisation of rest raw material from fisheries and other aquatic biomass
- Enforcement of the landing obligations given by the EU fishery policy
- More research on use of underused fish and other marine biomass
-  Develop regionally: pilot plants for proof of concept at semi-industrial scale; bio-refineries as ‘lighthouse’  
projects to encourage further investment 
Production 
costs
Support the reduction of blue production costs
- Provide partial coverage of R&D costs for entrepreneurs in the blue sector 
- Planning and building of clusters of blue production in the EU with biorefineries and other production / research facili-
ties
- Provide investment in silos and biorefinery facilities that can stabilise the input into processing industries 
Logistics and 
seasonality 
Support solutions for biomass processing
-  Support further scientific research on: impact of seasonality on biomass characteristics; crops and harvesting 
optimisation; logistical challenges and pre-processing techniques (biomass specific)
- Set up knowledge exchange on developing system of distributed production of marine biomass 
- Open data platform with data (e.g. from ongoing monitoring of water quality) 
Table 3: Challenges and solutions in Consumers and Value Chains
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SCIENCE, TECHNOLOGY   
AND INNOVATION
Better links and collaboration are needed to 
develop and deliver successful products to 
consumers. Furhtermore, improved coop-
eration between research and industry can 
have cross-cutting effects on the other spe-
cific challenges that have been identified. 
More collaboration would also help to 
reduce exploration costs, optimisation of 
multi-purpose screening on hotspots or 
sampling programs .
The availability of research infrastructures 
is essential to continue the development 
and use of outputs from marine biotech-
nology. The most urgent technological 
challenges are in the demonstration plant 
phase, and the upscaling to flagship/first-of-
a-kind, when economies of scale have not 
yet been achieved. 
Access to data, research results (including 
data from unsuccessful experiments) and 
data banks is considered a challenge that, 
when tackled, may further stimulate the 
development of the blue bioeconomy . Re-
search and industry need to be incentivised 
to share data. A big challenge is to unify / 
streamline the available data sources and 
portals that are avilable. Therefore, it is 
proposed to link blue bioeconomy projects 
with European initiatives to share and 
standardise data, making use of existing 
structures such as the European Open 
Science Cloud. 
Blue Bioeconomy Forum ~ Roadmap for the blue bioeconomy14
Science, Technology and Innovation
Challenges Solutions
Research-industry 
dialogue
Facilitate dialogue and cooperation between research and industry
- Develop measures to incentivise researchers / companies to collaborate
- Launch exchange programmes for students and staff in industry
Marine 
exploration
Support solutions for marine exploration
- Facilitate exploration of marine environment
Research 
infrastructures
Support a network of research infrastructures
- Mapping: optimise use of research infrastructures
-  Reduce gap of qualified people for running and maintaining research infrastructures – especially engineering 
profiles 
- Build a European blue bioeconomy ecosystem 
- Build research infrastructure and financial tools to sustainably use / operate (joint) facilities 
Access to data
Promote open data and access to research findings
-  Define structure of an open access results database, making use of existing data structures (e.g. EMODnet, 
EOSC)
- Construct an open access results database 
Table 4: Challenges and solutions in Science, Technology and Innovation
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EXAMPLES OF   
BLUE BIOECONOMY ACTIVITIES
The BBF also aimed at identifying and 
showcasing examples of projects and/
or SMEs that not only highlight Europe’s 
potential for the blue bioeconomy, but are 
also sufficiently close to commercialisation 
so that they would deserve attention from 
both public and private investors.The criteria 
for selection were:
~  Resources are microalgae, seaweed, 
fish by-products, organic materials from 
the sea, or novel sources (e.g. genetic 
information)
~  Value added applications are high value 
non-food (cosmetics, pharmaceutics), 
chemical building blocks, functional 
food or functional feed
~ Activities are undertaken after 2010
To assess the potential for industrial appli-
cation, the BBF examined the commercial 
potential, the potential for investors and 
estimated the technology readiness levels 
(TRL) (which is 4 or higher for all examples, 
with targets of TRL 5 and higher). Prefer-
ably, the examples also have Intellectual 
Property (IP) in the shape of patents. The 
estimates and expert judgement are based 
on a combination of desk research and 
interviews. For the examples chosen, the 
BBF sees a realistic potential for industrial 
application .
For each of the examples, the solutions 
from the Roadmap from which they will 
benefit the most are presented, based on 
the judgement of the BBF project team. 
Beside the examples mentioned in this 
brochure, there are many more projects 
and companies in the blue bioeconomy in 
Europe with great potential. 
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AtSeaNova is a Belgian company that sup-
plies turnkey solutions for industrial seaweed 
farming. The farms can be set up anywhere 
suitable for growing seaweed, and they can 
adapt to different sea and weather condi-
tions, which makes them a particularly viable 
and flexible option. The farms are sustain-
able, increase biodiversity, pick up excess 
nutrients from land-based activities, and 
generate a CO
2 mitigation effect as part of 
the seaweed breeding and growing process.
AtSeaNova has fully validated the technology 
and is ready to commercialise the seaweed 
farms. Geographically, the firm has set its 
The main competition faced by AtSeaNova 
and its customers in Europe comes from wild 
seaweed-harvesting companies.  
However, the natural presence of wild 
seaweed is uncertain due to climate change, 
some species have already disappeared in 
places. This phenomenon makes industrial 
seaweed farming solutions like AtSeaNova’s 
all the more important. 
sights initially on European sales, where the 
market for seaweed is currently small but 
with good growth potential. The Asian market 
also shows great promise.
Marketing efforts are focused on clients who 
can see the potential in seaweed farming.  
So far, the company has identified two 
potential targets. First, customers with 
knowledge or a background in the field, but 
with limited financial means to invest; and 
second are those able to invest, but with 
no expertise in seaweed breeding who may 
need AtSeaNova’s support services.
SEAWEED  
AT YOUR SERVICE
Belgian seaweed breeding business eyes off future markets 
for its full-service solutions
Country of origin 
Belgium
TRL-level 
9
Website 
www.atseanova.com
AtSeaNova will benefit from the promotion of 
existing and new funding mechanisms.
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BIOREFINING SEAWEED  
TO TACKLE  
CLIMATE CHANGE
Dutch group targets three climate change challenges: 
proteins, plastics and biodiversity
Danvos is a Dutch private company founded 
by a food technologist whose mission is to 
develop a biorefinery for seaweed and design 
applications with the new compounds. The 
seaweed-refining products have the potential 
to address three major societal challenges 
related to climate change: protein transition, 
biodiversity and bioplastics. 
Firstly, proteins extracted from seaweed by 
Danvos can replace proteins produced on 
land from both plant and animal sources. 
Secondly, biodiversity is affected by wide-
ly used  toxicagro chemicals, and Danvos’ 
seaweed products provide an alternative way 
to fertilise soils and leaves without disturb-
ing the environment. Thirdly, plastic can be 
created from seaweed, which makes it an 
eco-friendly substitute to fossil fuel-based 
plastics. The seaweed-refining process is 
replicable in other countries, especially 
because the company is willing to share the 
technology. 
Danvos is at an early commercial stage and 
actively looking for  partners to enter the 
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market. The commercial potential of the 
product is considerable because fertilisers 
and animal feed represent up to 40% of 
the world agrobusiness, and with investors 
Danvos will be in good position to capture 
some of this vast market. The team is also 
working on scaling up the volume it is able to 
produce in order to meet demand for large 
quantities . 
Danvos wishes to see a change in legislation 
that would encourage farmers to use more 
organic fertilisers and natural methods.  
They have tested the impact of replacing 
chemicals by seaweed organic fertilisers and, 
over a three-year period, observed tremen-
dous biodiversity gains, especially for soil 
life, insects and birds. 
Country of origin 
The Netherlands
TRL-level 
6
Website 
www.danvos.nl
Danvos will benefit from valorised ecosystem 
services.
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tions with similar meteorological conditions 
and infrastructure. A high market potential 
is expected. Due to current legislation, short 
term applications within Europe will most 
likely focus on high value-added oils.
To capitalise on this innovation and gain 
market share, D-factory must raise aware-
ness about Dunaliella’s unique qualities, 
D-factory is a research and development 
project gathering experts from nine different 
European countries to grow, bio-refine and 
commercialise components developed from 
a unique species of algae, called Dunaliella.
Dunaliella grows not by consuming natural 
resources but by absorbing CO
2 and solar 
energy, both available in abundance.  
Cultivated and properly handled and extract-
ed, it can be used to create a high-value ma-
terial, called 9-cis-β-carotene. This specific 
type of carotene has a range of applications, 
the most important and value-generating 
one being its pharmaceutical and medical 
uses. Indeed, 9-cis-β-carotene has the poten-
tial to cure patients with eye diseases and 
skin conditions like psoriasis. 
By-products can also be commercialised as 
food additives or animal feed. There is also 
notable interest from the pigment industry 
because 9-cis-β-carotene offers different 
possibilities, notably as natural food color-
ants . 
The main D-factory production is located in 
Spain, but could be replicated in other loca-
BIOTECH  
BONUS TIME 
A unique algae tackles climate change and promises  
a biotech bonus at the same time
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clearly differentiating it from other types of 
beta-carotene produced, notably chemical 
ones. The 9-cis-β-carotene refined from 
Dunaliella is of higher quality than equiva-
lents on the market, which explains its higher 
price. The product is not on the market yet as 
D-factory is still conducting clinical trials.
Country of origin 
European Union; production location Spain
TRL-level 
6
Website 
www.d-factoryalgae.eu
Increased consumer awareness and acceptance 
would help D-factory.
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NEW WIN-WIN  
PERSPECTIVES ON  
A GREEN NUISANCE
French firm takes a source of aggravation and transforms it 
into bio-friendly plastic
green macroalgae, but also in desert land, 
industrial wastelands and land unsuitable for 
agriculture . 
Pre-orders and letters of intent from future 
customers illustrate the commercial potential 
of Eranova’s solution. Before being formally 
launched on the market, however, Eranova’s 
technology first needs to pass a pre-industri-
alisation phase, which requires funding. 
Therein lies a problem. Although the unusual 
industrial usage of bio-sourced plastics 
is promising and desirable, it also makes 
Eranova ineligible for most public funding 
programmes that are not designed for hybrid 
industrial sectors. Private investors, and 
more specifically industrialists and commer-
cial banks, have shown interest in the project, 
so the prospects still look bright. 
Eranova is a French start-up that creates 
plastic from green macroalgae. The presence 
of this macroalgae in coastal regions is a 
major source of pollution and the toxic gas-
ses they emit pose a risk to oceans, marine 
wildlife, and human health. 
Limiting the impact and spread of green 
algae is also a major cost for local author-
ities. The technology developed by Eranova 
transforms this nuisance into a new-genera-
tion bioplastic, with diverse industrial usages 
such as cosmetics and packaging. In other 
words, Eranova provides a win-win solution 
to reduce coastal pollution and an alternative 
to much-maligned fossil fuel-based plastics. 
Besides its positive environmental effects, 
Eranova expects to be able to generate em-
ployment, through the creation of up to 320 
new jobs. It has the potential to be replicated 
in other coastal environments suffering from 
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Country of origin 
France
TRL-level 
7
Website 
www.eranovabioplastics.com
Eranova will benefit from valorised ecosystem 
services and advice on business and financing.
SHRIMP SHELLS  
THREE WAYS
Innovative Icelanders transform a common fisheries bio-
waste into a big bio-opportunity
see legislation in the food and nutraceutical 
markets harmonised across Europe. Current-
ly, rules are country dependent and there are 
inconsistencies between them, which makes 
it difficult to find a location for testing and to 
comply with the legislation. 
Environmental issues are an important 
concern for Genis’ business as well. Climate 
change is triggering a displacement of 
Genis is a company from Iceland that has 
developed several clever business opportuni-
ties associated with a common fish-process-
ing by-product, namely shrimp shells. Given 
their special properties, shells from these 
crustaceans can be transformed into a range 
of value-adding products.
Firstly, Genis sells food supplements made 
from shell components for people suffering 
from ageing-associated problems such as 
stiffness, aches and lethargy. Those prod-
ucts are already available on the market in 
Iceland, Ireland and the UK under the brand 
Benecta®. Secondly, the firm is developing 
medical devices containing chitin derivates 
from shell components. The market for this 
activity is mainly in Europe. In their clinical 
studies they also collaborate with Danish 
hospitals. Thirdly, Genis is working on active 
pharmaceutical ingredients, but this activity 
is a work in progress and takes many years. 
The commercial potential of these three 
sectors of activity is considerable and high 
profits are anticipated. 
Genis employs 30 people, and they all work 
in R&D and manufacturing. Commercialisa-
tion of the company’s products is currently 
outsourced. The team has already filed 
several patents and owns its technology. 
In order to grow faster, Genis would like to 
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shrimps to the North and this directly affects 
the availability of biomass (the shells) and 
associated activities within the company. 
Country of origin 
Iceland
TRL-level 
7
Website 
https://simecos.benecta.is/about-us/
Simplified licence and permit applications and sup-
port for Novel Food Regulation will help Genis..
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FUTURE-PROOFING  
WITH SEAWEED
Unusual as it sounds, the future is in sustainable seaweed; 
one company is gearing up for it 
more funding, they would also like to work 
on mitigating biological threats posed by 
microorganisms that can attack seaweed. 
Unfortunately, the legislation regarding re-
search on seaweed, including cross-breeding, 
is unclear and lacks the flexibility Hortimare 
needs going forward.  
Hortimare is a leader in the breeding and 
propagating of sustainable seaweed. For five 
years it has been selling high-quality starting 
material used to grow healthy seaweed. It 
also provides advice and support to novice 
seaweed farmers, helping them develop and 
expand their activity. 
Hortimare positions itself as the first step 
in the value chain of a burgeoning seaweed 
sector. While the technology is ready and 
the sector is gaining traction, Hortimare is 
working on reinforcing it, in particular by 
improving the yield predictability of seaweed 
harvests. This aspect is crucial to convince 
farmers but also large companies to grow 
this marine crop. 
There are many uses for seaweed and 
experts are forecasting huge market growth 
potential – up to 100-fold in harvest volumes 
within ten years. Hortimare is gearing up 
for this increased demand, and adapting to 
international markets by developing different 
seaweeds according to diverse geographical 
conditions. 
Hortimare has a dedicated R&D team 
working on cross-breeding programmes to 
make more resilient seaweed species. With 
Country of origin 
The Netherlands
TRL-level 
7
Website 
www.hortimare.com
Hortimare will benefit from advice on business and 
financing and the promotion of existing and new 
funding mechanisms
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Candidates would need to be highly skilled, 
which might be difficult to find, management 
acknowledges. In the future, KeyNatura is 
also seeking closer collaboration between 
industry and universities, to facilitate clinical 
trials needed to move forward and improve 
marketing efforts.
KeyNatura specialises in pure and natural 
antioxidant products made from microalgae. 
The products are already available on the 
food supplements market, which includes 
nutraceuticals. The demand for those is high 
because consumers are increasingly looking 
for natural and nutraceutical beauty prod-
ucts . KeyNatura is in the process of scaling 
up its production to meet this demand.
In order to produce and extract antioxidants 
from microalgae, KeyNatura uses a unique 
technology. Microalgae are grown in a closed 
tank-based photobioreactor with artificial 
light, through a process that is entirely 
carbon negative. The production takes place 
24/7 and all year round. It is not location 
dependent, which means it can be replicated 
in other countries. 
KeyNatura has patented its algae cultivation 
technology and aims to further commercial-
ise it. In the long run, KeyNatura anticipates 
two kinds of customers emerging: retail 
customers of its antioxidant products; and 
algal biomass companies interested in its 
cultivation technology. 
KeyNatura also plans to make its production 
a zero-waste process by adding value to 
every part of the biomass. 
The company plans to hire more than 35 
employees to achieve its ambitious goals. 
BRINGING OUT  
THE NATURAL BEAUTY
Nutraceutical firm’s ambitious plan for scaling up production 
and scaling down waste
Country of origin 
Iceland
TRL-level 
6
Website 
https://keynatura.com/
Availability of skilled and qualified human 
resources is an important Roadmap solution for 
KeyNatura. More cooperation between research 
and industry would help as well.
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FISH FARM  
VACCINE-DELIVERY  
LOOKS TO SCALE UP
Microalgae turned into a clever vehicle for delivery of  
therapeutic agents to fight disease in aquaculture
protective immune response.  Finally, there 
are no oral delivery strategies available to 
vaccinate or administer therapeutic agents to 
shrimps. As a result, there may be as much 
as 1.5 Billion USD in losses of shrimp stocks 
each year.
Given the stakes and the high costs seafood 
producers face in preventing and dealing 
with disease, global investment in fish health 
MicroSynbiotiX is a biotechnology start-up 
company aimed at developing a novel oral 
drug delivery technology. The technology 
enables farmers to incorporate therapeutic 
agents in animal feed in order to protect the 
animals against a target disease. The primary 
market for MicroSynbiotiX is aquaculture since 
it is the fastest growing market and the tech-
nology has an excellent product-market fit.
This new kind of vaccination is a direct 
competitor to traditional injection methods, 
and is likely to become increasingly popular. 
Seafood producers currently use hand held 
injection techniques to vaccinate individual 
fish which is labour-intensive and expensive. 
Furthermore, existing injection vaccines for 
livestock are not always viable for the aqua-
culture sector and as they do not necessarily 
provide complete protection, the farmer will 
still have to use antibiotics. In addition, the 
problem with conventional vaccines such 
as live / inactivated bacteria (bacterins), is 
that they also contain other toxins from the 
bacteria, which can also generate an immu-
nosuppressive effect, preventing a long-term 
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is big business, making the commercial op-
portunities for MicroSynbiotiX considerable. 
With the increase in fish diseases induced by 
global warming, the market will only grow 
bigger. 
It would help MicroSynbiotiX if funding and 
support from European funding agencies 
were easier to find and apply for. The funds 
are often too risk-averse to invest in a pro-
ject as ambitious as MicroSynbiotiX’s. 
Country of origin 
Ireland
TRL-level 
5
Website 
www.microsynbiotix.com
MicroSynbiotiX will benefit from advice on business 
and financing and the promotion of existing and 
new funding mechanisms.
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ADD A PINCH OF  
BLUE MUSSEL POWDER!
Award-winning Swedish start-up looks to grow its mussel 
extracts business internationally 
production facilities could be introduced in 
Europe, especially where mussel production 
is well established. 
Scaling up will also go hand-in-hand with 
building up awareness and trust among 
customers, as the mussels are a traditional 
source of protein, but the form of dried pow-
der is a unique way of using it. 
Musselfeed is a Swedish start-up that has 
developed an industrial process to extract 
valuable products from blue mussels. The 
mussel meat is a high-quality nutritional 
product rich in proteins and in omega-3 fatty 
acids. The company transforms it into a dried 
powder that can be used in food products, in 
collaboration with chefs, and in pet food. 
The mussel shells are high in calcium and 
have applications in agriculture, especially in 
fertilisers for now, but other possibilities are 
envisioned. Given its many applications, the 
market potential of Musselfeed’s products 
is huge. Similar products are imported to 
Europe from New Zealand today. 
Musselfeed is a recognised player in Europe, 
as highlighted by the two awards it garnered 
from Swedish and European institutions. 
Its activity is not only sustainable but also 
regenerate nature, since mussel cultivation 
in organic farms has a low CO
2 and envi-
ronmental footprint and also bring nutrients 
back to land.
Musselfeed started out as a research project 
in 2013 and was then transformed into a 
B2B company, which has now set its sights 
on scaling up. The products are already being 
commercialised, but only at the kilogram-lev-
el. However, Musselfeed is working on scaling 
them up to tonne-volumes. Also other 
Country of origin 
Sweden
TRL-level 
4
Website 
http://musselfeed.com/
Increased valorisation of side products would help 
Musselfeed.
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SEAGRASS PRODUCTS,  
AS NATURE INTENDED
Greek company rides blue bioeconomy wave as interest 
grows in its sea plant-based materials 
Competition from less sustainable mate-
rials is still a challenge for Phee, allowing 
competitors to sell cheaper products. Public 
Phee is a Greek start-up that has created 
and sells a new sustainable bio-composite 
material. Made from the dead leaves of a 
Mediterranean sea plant, it has various com-
mercial applications . 
This material is used to produce smartphone 
cases, sunglasses and wooden boxes that 
are already sold on the market. Most prod-
ucts are co-branded with design companies. 
Other industrial applications are also possi-
ble for the material, and Phee is currently ex-
panding its activities into the interior design, 
architecture and construction sectors. Phee 
is also working with a luxury hotel to help it 
become more sustainable. 
Phee’s compass is set on global expansion. 
Products are currently sold by several re-
tailers in Greece, but it is developing exports 
to Benelux, Australia and North America. 
Phee is now fundraising in order to further 
develop its product line and launch the first 
store (retail point) in Greece with a plan of 
opening more stores in Europe in the next 
three years. A big advantage is that Phee’s 
products cannot be replicated anywhere, 
since the seagrass used is only located in the 
Mediterranean Sea, and production depends 
on its collection by local municipalities. Phee 
takes care to harvest the seagrass in a sus-
tainable way, not in an industrial fashion. 
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awareness of sustainable solutions like 
Phee’s must increase to encourage custom-
ers to buy quality ‘green’ and ‘blue’ products. 
There are good signs ahead, though. Phee 
has gained recognition as an up-and-coming 
player, having recently won several start-
up awards, including being selected in the 
Forbes 30U30 industry list in 2018. 
Country of origin 
Greece
TRL-level 
4
Website 
https://phee.gr/
Phee would benefit from increased consumer aware-
ness and acceptance.
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BLUE BIOPHARMA-BASED 
DRUGS TO TARGET  
CHRONIC PAIN
Biopharma-based company sets its sights on the vast  
market for novel chronic pain drugs 
Pollution is a concern for Sea4Us because 
of its effects on biodiversity. At the species 
level, even the loss of one organism, which 
may produce a unique or interesting mole-
cule, has repercussions. The displacement of 
marine species might have negative impacts 
on their ability to produce these molecules 
of interest. Hence, the location of Sea4US’ 
Sea4Us is a biopharmaceutical company 
which uses marine compounds for therapies 
of unmet clinical needs. More specifically, it 
is exploiting the potential of invertebrates, 
namely  sponges and anemones to cure 
chronic pain. Since 20% of the global popula-
tion is estimated to suffer from some form 
of chronic pain, the market is vast. 
The drugs are still in the development phase, 
so they are not being commercialised yet. 
Two promising components/compounds are 
currently under investigation, both come 
from marine organisms but, importantly, can 
be replicated, either by chemical-synthesis or 
through bacteria. 
Before launching the eventual products on 
the market, Sea4Us will perform the first 
stages of clinical tests, which require invest-
ment and partnering with bigger ‘Pharma 
players’. Sea4Us has already managed to 
gather funding from different sources, in-
cluding European funds and private pharma-
ceutical investors . 
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activities is crucial; marine-organism pros-
pecting takes place in very specific locations. 
Minimising the distance between the harvest 
and laboratory is also essential, to cut trans-
port costs and keep carbon emissions down. 
The Sea4Us team is made up of 13 people 
who work in two laboratories, but they also 
own a marine station and are building a 
research centre with diving and prospecting 
facilities. This equipment allows the team to 
continue the hunt for new molecules from 
marine organisms to further develop novel 
biopharma products. 
Country of origin 
Portugal
TRL-level 
4
Website 
http://sea4us.pt/ 
Sea4Us will benefit from support for marine 
exploration.
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ALGAE ALCHEMY,  
FROM SOLAR PANELS  
TO MOISTURISER
Silica derived from algae is yet another clever  
blue bioeconomy application, the story behind it 
public. The company also faces an uphill bat-
tle dealing with legislative issues, obtaining 
permits and the associated administrative 
costs . 
Undaunted, and with its sights set on growth, 
the company plans to hire five additional 
people, which will create jobs for marine 
biologists who sometimes struggle to find 
employment in their sector. 
The main product developed by Swedish  
Algae Factory is silica, an advanced na-
no-porous material extracted from microal-
gae. Silica has two major usages: firstly, it is 
used in solar panels as efficiency enhancer; 
and secondly, it is applied in luxury personal 
care products as an absorbent and moistur-
ising agent. The remaining organic biomass 
can be put to good use in animal feed, fer-
tiliser or fuel, to name a few. Swedish Algae 
Factory has already filed a patent to protect 
its unique technology. 
Currently, silica is available on the market, 
but only under its personal care applica-
tion. To be commercialised for solar energy 
purposes, larger volumes of silica need to be 
produced. This is very likely to happen, since 
a scale up is planned for 2021 thanks to 
funding from the European Union. The funds 
will help to expand Swedish Algae Factory’s 
production and expand its market globally; 
sales are currently concentrated in the Nor-
dic countries. 
The team is aware that entering new mar-
kets with an innovative technology can be 
quite challenging because customers often 
need some convincing, but in general the 
sustainability of the products motivates the 
Country of origin 
Sweden
TRL-level 
4
Website 
https://swedishalgaefactory.com/ 
Simplified licence and permit applications will help 
the Swedish Algae Factory.
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Vetik is already well recognised in the blue 
bioeconomy sector, as it has won several 
awards and competitions from different 
European countries. The company has been 
invited to participate in business accelera-
tor programmes and benefited from public 
funding.  
Vetik is an Estonian project exploring the 
potential of using red seaweed biomass. The 
team is extracting red colourant from the 
sea plant for use in cosmetics and as a nat-
ural substitute to today’s unhealthy synthetic 
colorants . 
Most of the colourants in cosmetics today 
are made from petroleum or insects, and 
there is a growing demand for natural and 
vegan alternatives. Over 20 cosmetic com-
panies have already shown interest in Vetik’s 
work. 
Before being commercialised, the colourants 
and prototypes will be further analysed to 
assess their usability and specific cosmetic 
applications . Small-scale commercialisation 
is expected by the summer of 2020. Vetik 
benefits from a considerable advantage 
because it has good access to a stock of 
seaweed that can be harvested sustainably 
at an industrial scale. 
However, they are also looking to grow their 
own seaweed. For further scale-up, it will be 
necessary to develop their own production, 
and a more efficient extraction process that 
uses all of the leftover biomass as well. They 
are looking for partners for these steps, in-
cluding bringing in outside help because the 
necessary expertise about seaweed might 
not be available in Estonia.
ANOTHER COLOURFUL  
USE FOR SEAWEED!
Award-winning Estonian project sees red seaweed as  
the future in natural colourants 
Country of origin 
Estonia
TRL-level 
4
Website 
www.vetik.eu
Vetik would benefit from support for a network 
of research infrastructures and the availability of 
skilled and qualified human resources.
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